Senior Accountant
About this role
Scholar Rock is a late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the Company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.
Summary of Position:
The Senior Accountant will play an important role in supporting the monthly close process, maintaining accurate financial records, and helping ensure the Company’s accounting processes are timely, well controlled, and scalable as the business grows. This role will be responsible for preparing journal entries, account reconciliations, and supporting schedules across key areas such as cash, prepaid expenses and accruals, G&A activity, fixed assets, and other general ledger accounts.
The Senior Accountant will collaborate closely with members of the Accounting team to support internal reporting, external reporting, audit requests, SOX compliance, and process improvement initiatives. This position is a great opportunity for someone who is detail-oriented, organized, pro-active, and excited to gain exposure to a broad range of accounting areas within a growing public biotechnology company. The ideal candidate will be comfortable working in a fast-paced environment, able to manage multiple priorities, and willing to take initiative. This role requires strong Excel skills, clear communication, attention to detail, and a team-oriented approach.
- Prepare month-end journal entries and account reconciliations/supporting schedules across cash, prepaid expenses, fixed assets, accruals, G&A activity, and other GL accounts
- Perform account analyses, investigate variances, and support timely, accurate completion of monthly/quarterly close activities
- Prepare schedules and documentation supporting internal reporting, external reporting, audits, quarterly reviews, and SOX compliance
- Partner with cross-functional teams to gather information needed for accounting entries and analysis
- Support efforts to continuously drive cross-functional improvements, as well as create process documentation
- Execute special ad-hoc projects as requested to support the greater Finance team
- Bachelor’s degree in Accounting, Finance, or related field
- 3-5 years of relevant accounting experience
- CPA or equivalent is preferred
- Life sciences, biotechnology, or pharmaceutical industry experience preferred
- Public company experience preferred
- NetSuite and/or SAP experience preferred
- Experience with month-end close, journal entries, reconciliations, and account analysis
- Exposure to SOX controls and audit support preferred
- Strong organizational skills and ability to manage multiple priorities in a fast-paced environment
- Ability to work independently, take initiative, and follow through on open items
- Strong communication skills and ability to work effectively with team members and cross-functional partners
- Strong Excel and computer skills required
- Strong attention to detail and ability to produce accurate, well-supported work
- Curious, proactive, and motivated to learn and grow within a developing accounting organization
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Company at a glance
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock on X.
For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/
For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy/
Tired of cold applications?
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Know someone who'd be great for this?